Celecoxib for the treatment of non muscle invasive bladder cancer. Results from the first phase II clinical trial

被引：1
|
作者：
Pagliarulo, V. [1 ]
Martines, I. [1 ]
Telari, S. [1 ]
Ancona, P. [1 ]
Trerotoli, P. [2 ]
Albo, G. [1 ]
Pagliarulo, A. [1 ]
机构：
[1] Univ Bari, Sezione Urol, DETO, I-70121 Bari, Italy
[2] Univ Bari, Dipartimento Med Interna & Med Publ, I-70121 Bari, Italy
来源：
EUROPEAN UROLOGY SUPPLEMENTS | 2008年 / 7卷 / 03期
关键词：
D O I：
10.1016/S1569-9056(08)60909-4
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
912
引用
收藏
页码：299 / 299
页数：1
相关论文
共 50 条
  • [1] RESULTS OF A PHASE II/III TRIAL OF CELECOXIB TO PREVENT RECURRENCE OF NON-MUSCLE INVASIVE BLADDER CANCER
    Lerner, Seth P.
    Lee, J. J.
    Liu, S.
    Grossman, H. Barton
    Czerniak, Bogden
    Richmond, E.
    Eagle, C.
    Lippman, Scott
    Sabichi, Anita L.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 71 - 71
  • [2] Treatment of non-muscle invasive bladder cancer.
    Danforth, Kim N.
    Lee, Janet S.
    Luong, Tiffany Q.
    Munoz-Plaza, Corrine E.
    Hahn, Erin Elizabeth
    Mittman, Brian S.
    Loo, Ronald K.
    Williams, Stephen G.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] Celecoxib for the treatment of non-muscle invasive bladder cancer (NMIBC): Results of the randomised BOXIT trial (CRUK/07/004)
    Kelly, J.
    Maynard, L.
    Mostafid, H.
    Huddart, R.
    Bogle, R.
    Cresswell, J.
    Johnson, M.
    Protheroe, A.
    Burnett, S.
    Hall, E.
    BJU INTERNATIONAL, 2015, 115 : 11 - 12
  • [4] Study protocol of a phase II clinical trial of oral metformin for the intravesical treatment of non-muscle invasive bladder cancer
    Remco J. Molenaar
    Jons W. van Hattum
    Iris S. Brummelhuis
    Jorg R. Oddens
    C. Dilara Savci-Heijink
    Egbert R. Boevé
    Saskia A. van der Meer
    J. Fred Witjes
    Michael N. Pollak
    Theo M. de Reijke
    Johanna W. Wilmink
    BMC Cancer, 19
  • [5] Study protocol of a phase II clinical trial of oral metformin for the intravesical treatment of non-muscle invasive bladder cancer
    Molenaar, Remco J.
    van Hattum, Jons W.
    Brummelhuis, Iris S.
    Oddens, Jorg R.
    Savci-Heijink, C. Dilara
    Boeve, Egbert R.
    van der Meer, Saskia A.
    Witjes, J. Fred
    Pollak, Michael N.
    de Reijke, Theo M.
    Wilmink, Johanna W.
    BMC CANCER, 2019, 19 (01)
  • [6] Clinical trial design for non-muscle-invasive bladder cancer
    Tan, Wei Shen
    Hall, Emma
    Kamat, Ashish M.
    Kelly, John D.
    NATURE REVIEWS UROLOGY, 2023, 20 (10) : 575 - 576
  • [7] Clinical trial design for non-muscle-invasive bladder cancer
    Wei Shen Tan
    Emma Hall
    Ashish M. Kamat
    John D. Kelly
    Nature Reviews Urology, 2023, 20 : 575 - 576
  • [8] A phase II trial of gemcitabine and celecoxib for metastatic pancreatic cancer.
    Xiong, HQ
    Hess, KR
    Kayaleh, OR
    Goodwin, JW
    Banerjee, T
    Sinclair, SS
    Fisch, MJ
    Wolff, RA
    Abbruzzese, JL
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 351S - 351S
  • [9] Long-term results of a phase II study of synchronous chemo radiotherapy in muscle invasive bladder cancer.
    Hussain, SA
    Stocken, DD
    Peake, DR
    Glaholm, JG
    Zarkar, A
    Wallace, DMA
    James, ND
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 403S - 403S
  • [10] Bladder cancer susceptibility polymorphisms and mortality from non-muscle and muscle-invasive bladder cancer.
    Leeming, Reno C.
    Zens, Michael S.
    Seigne, John D.
    Christensen, Brock C.
    Gilbert-Diamond, Diane
    Karagas, Margaret R.
    Passarelli, Michael N.
    CLINICAL CANCER RESEARCH, 2020, 26 (15) : 54 - 55
12345